Recombinant Human STX17 Protein ，His

STX17, a member of the syntaxin family of proteins, plays a crucial role in the trafficking and fusion of vesicles within cells, particularly in the context of autophagy and exocytosis. The importance of STX17 has been increasingly highlighted in recent years, as it is involved in the regulation of autophagic processes, which are vital for cellular homeostasis, nutrient recycling, and the response to stress. Dysfunction or dysregulation of STX17 has been implicated in various diseases, including neurodegenerative disorders and cancer, where impaired autophagy contributes to cellular dysfunction and disease progression. Research into STX17 recombinant protein has aimed to elucidate its molecular mechanisms, interactions with other autophagy-related proteins, and its potential as a therapeutic target. This recombinant protein is pivotal for in vitro studies, allowing scientists to dissect the pathways of vesicle trafficking and autophagic flux in a controlled environment. Understanding STX17's role within these pathways may lead to novel insights into how to manipulate autophagic processes for therapeutic benefit in diseases characterized by autophagy impairment. As such, STX17 recombinant protein serves as a valuable tool for both fundamental studies of cell biology and the development of targeted therapies in the context of diseases where STX17-related pathways are disrupted.